Aglatimagene Besadenovec

· Candel Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aglatimagene Besadenovec, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec [Phase 2]